Facial Injectables Market Size, Share & Industry Analysis
商品番号 : SMB-67072
| 出版社 | Fortune Business Insights |
| 出版年月 | 2024年10月 |
| ページ数 | 148 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,850 |
| 種別 | 英文調査報告書 |
Growth Factors of Facial Injectables Market
The facial injectables market size was valued at USD 8.93 billion in 2023, and the market is now projected to grow from USD 9.54 billion in 2024 to USD 17.24 billion by 2032, exhibiting a CAGR of 7.7% during the forecast period of 2024-2032.
顔面注射剤の市場規模は2023年に89億3,000万米ドルと評価されており、現在市場は2024年の95億4,000万米ドルから2032年までに172億4,000万米ドルに成長すると予測されており、2024年から2032年の予測期間中に7.7%のCAGRを示しています。
According to COVID-19 impact, the overall demand for cosmetic products has dropped drastically across global markets, and therefore, the sale of cosmetics has also plunged. Top market stakeholders cut their revenues from facial injectables during the second quarter of 2020 significantly. Pandemic restrictions and lockdowns also reduced opportunities to undergo aesthetic procedures, which also affected this industry. Therefore, the cosmetic market was on less favorable ground as tested by these challenges during this period.
In the last ten years, there has been increased quests in cosmetic surgeries and minimally invasive or non-surgical procedures, including botulinum Toxin and dermal fillers. Several people go for such treatments if only to make them look young without having to go through surgeries which are invasive. Procedures that require invasive means require a lot of time in the recovery process, as well as posing various risks to the patient; therefore, non-invasive procedures are preferable. This trend is in line with the general trends observed towards more affordable and safer cosmetic procedures.
One of the trends in the market is a tendency towards the increase of demand for non-surgical or least invasive aesthetic procedures for different age, including male consumers. Surgeries such as botulinum toxin injections, dermal fillers, and other cosmetic procedures are becoming popular among men to aid in enhancing their looks to improve on the aspect of aging. This change is due to altering the perception that the grooming of males and cosmetics in general are appropriate only for females, influencing the increase in attractiveness of cosmetic procedures among men. For these reasons, the market for such treatments remains wide open.
Comprehensive Analysis of Facial Injectables Market
The facial injectables market growth is also increasing exponentially because of the segmentation of its market. This market expansion rightly provides a thorough market breakdown near to the industry considering the leading supply and demand forces. These segmentations are methodically segregated by type analysis, by application analysis and by end-user analysis. By type analysis incudes botulinum toxin, collagen, hyaluronic acid, calcium hydroxylapatite, Poly-L-lactic Acid (PLLA), polymethyl-methacrylate microspheres (PMMA), fat injection, and others. By application analysis incudes wrinkle reduction, facelift, acne scar treatment, lip enhancement, lipoatrophy treatment, and others. By end-user analysis incudes hospitals & ambulatory surgery centers, dermatology & cosmetic clinics, and others.
The North America region lead the facial injectables market share by benefitting a market size of USD 4.26 billion in 2023 due to highly aware and economically stable population.
Top players in the market have their responsibility of healthcare industrial prospectus growth of the retailing industry and the markets. These players include, Allergan Aesthetics (AbbVie Inc.), Ipsen Pharma, Merz Pharma, GALDERMA, BIOPLUS CO., LTD., Bioxis Pharmaceuticals, Sinclair (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox, Prollenium Medical Technologies these market players provide a level-playing competitive landscape.
In October 2023, Sinclair and ATGC Co., Ltd. entered a strategic collaboration, granting Sinclair a global exclusive license to develop and commercialize ATGC’s botulinum toxin product, ATGC-110, for treating glabellar lines.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 7.7% from 2024 to 2032
Unit Value (USD Billion)
Segmentation By Type
- Botulinum Toxin
- Collagen
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Poly-L-lactic Acid (PLLA)
- Polymethyl-methacrylate Microspheres (PMMA)
- Fat Injection
- Others
By Application
- Wrinkle Reduction
- Facelift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Lip Enhancement
- Others
By End-user
- Hospitals & ASCs
- Dermatology and Cosmetic Clinics
- Others
By Region
- North America (By Type, Application, End-user, and Country)
- U.S.
- Canada
- Europe (By Type, Application, End-user, and Country/Sub-region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Type, Application, End-user, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Overview of Facial Injection Procedures by Type, By Key Countries, 2023
4.2. Pricing Analysis
4.3. Key Industry Developments, By Key Players
4.4. New Product Launches, By Key Players
4.5. Key Industry Trends
4.6. Impact of COVID-19 on the Market
5. Global Facial Injectables Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Botulinum Toxin
5.1.2. Collagen
5.1.3. Hyaluronic Acid (HA)
5.1.4. Calcium Hydroxylapatite (CaHA)
5.1.5. Poly-L-lactic Acid (PLLA)
5.1.6. Polymethyl-methacrylate Microspheres (PMMA)
5.1.7. Fat Injection
5.1.8. Others
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Wrinkle Reduction
5.2.2. Facelift
5.2.3. Acne Scar Treatment
5.2.4. Lipoatrophy Treatment
5.2.5. Lip Enhancement
5.2.6. Others
5.3. Market Analysis, Insights and Forecast – By End-user
5.3.1. Hospitals & ASCs
5.3.2. Dermatology and Cosmetic Clinics
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Facial Injectables Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Botulinum Toxin
6.1.2. Collagen
6.1.3. Hyaluronic Acid
6.1.4. Calcium Hydroxylapatite
6.1.5. Poly-L-lactic Acid (PLLA)
6.1.6. Polymethyl-methacrylate Microspheres (PMMA)
6.1.7. Fat Injection
6.1.8. Others
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Wrinkle Reduction
6.2.2. Facelift
6.2.3. Acne Scar Treatment
6.2.4. Lipoatrophy Treatment
6.2.5. Lip Enhancement
6.2.6. Others
6.3. Market Analysis, Insights and Forecast – By End-user
6.3.1. Hospitals & ASCs
6.3.2. Dermatology and Cosmetic Clinics
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Facial Injectables Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Botulinum Toxin
7.1.2. Collagen
7.1.3. Hyaluronic Acid (HA)
7.1.4. Calcium Hydroxylapatite (CaHA)
7.1.5. Poly-L-lactic Acid (PLLA)
7.1.6. Polymethyl-methacrylate Microspheres (PMMA)
7.1.7. Fat Injection
7.1.8. Others
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Wrinkle Reduction
7.2.2. Facelift
7.2.3. Acne Scar Treatment
7.2.4. Lipoatrophy Treatment
7.2.5. Lip Enhancement
7.2.6. Others
7.3. Market Analysis, Insights and Forecast – By End-user
7.3.1. Hospitals & ASCs
7.3.2. Dermatology and Cosmetic Clinics
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Facial Injectables Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Botulinum Toxin
8.1.2. Collagen
8.1.3. Hyaluronic Acid (HA)
8.1.4. Calcium Hydroxylapatite (CaHA)
8.1.5. Poly-L-lactic Acid (PLLA)
8.1.6. Polymethyl-methacrylate Microspheres (PMMA)
8.1.7. Fat Injection
8.1.8. Others
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Wrinkle Reduction
8.2.2. Facelift
8.2.3. Acne Scar Treatment
8.2.4. Lipoatrophy Treatment
8.2.5. Lip Enhancement
8.2.6. Others
8.3. Market Analysis, Insights and Forecast – By End-user
8.3.1. Hospitals & ASCs
8.3.2. Dermatology and Cosmetic Clinics
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. New Zealand
8.4.7. Southeast Asia
8.4.8. Rest of Asia Pacific
9. Latin America Facial Injectables Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Botulinum Toxin
9.1.2. Collagen
9.1.3. Hyaluronic Acid (HA)
9.1.4. Calcium Hydroxylapatite (CaHA)
9.1.5. Poly-L-lactic Acid (PLLA)
9.1.6. Polymethyl-methacrylate Microspheres (PMMA)
9.1.7. Fat Injection
9.1.8. Others
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Wrinkle Reduction
9.2.2. Facelift
9.2.3. Acne Scar Treatment
9.2.4. Lipoatrophy Treatment
9.2.5. Lip Enhancement
9.2.6. Others
9.3. Market Analysis, Insights and Forecast – By End-user
9.3.1. Hospitals & ASCs
9.3.2. Dermatology and Cosmetic Clinics
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Facial Injectables Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Botulinum Toxin
10.1.2. Collagen
10.1.3. Hyaluronic Acid (HA)
10.1.4. Calcium Hydroxylapatite (CaHA)
10.1.5. Poly-L-lactic Acid (PLLA)
10.1.6. Polymethyl-methacrylate Microspheres (PMMA)
10.1.7. Fat Injection
10.1.8. Others
10.2. Market Analysis, Insights and Forecast – By Application
10.2.1. Wrinkle Reduction
10.2.2. Facelift
10.2.3. Acne Scar Treatment
10.2.4. Lipoatrophy Treatment
10.2.5. Lip Enhancement
10.2.6. Others
10.3. Market Analysis, Insights and Forecast – By End-user
10.3.1. Hospitals & ASCs
10.3.2. Dermatology and Cosmetic Clinics
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.4.1. GCC
10.4.2. South Africa
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Profiles of Players Operating in the Market
11.2.1. Allergan Aesthetics (AbbVie Inc.)
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Ipsen Pharma
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Merz Pharma
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. GALDERMA
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. BIOPLUS CO., LTD.
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Bioxis Pharmaceuticals
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Sinclair (Huadong Medicine Co., Ltd.)
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. Revance Therapeutics, Inc.
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Medytox
11.2.9.1. Overview
11.2.9.2. Products & Services
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. Prollenium Medical Technologies
11.2.10.1. Overview
11.2.10.2. Products & Services
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
Fortune Business Insights（フォーチュンビジネスインサイツ）は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
| シングルユーザ | マルチユーザ | エンタープライズ |
| USD4,850 | USD5,850 | USD6,850 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス ※レポートタイトルにより異なる場合がございます。詳細はお問合せください。
- シングルユーザライセンス
- 提供ファイル：PDF（印刷不可）
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 提供ファイル：PDF（印刷不可）＋Excel（印刷不可）
- 同一企業内6名までレポートファイルのご共有が可能です。
- エンタープライズライセンス
- 提供ファイル：PDF（印刷可能）＋Excel（印刷可能）
- 同一企業内人数無制限でレポートファイルのご共有が可能です。
- シングルユーザライセンス
- 納品方法
- Eメール
- 納期
- レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。
最新調査レポート